Methylation Status of Alu and LINE-1 Interspersed Repetitive Sequences in Behcet’s Disease Patients

Table 3

Alu methylation frequency of BD patients and healthy controls. The results are represented as the average ± standard deviation.

	%  C	%  CC	%  CC	%  CC	%  CC	%  CC + CC
PBMC control ()	42.14 ± 2.07	14.06 ± 2.96	31.90 ± 2.28	24.25 ± 1.08	29.79 ± 2.08	56.15 ± 2.99
PBMC active ()	41.57 ± 0.92	13.72 ± 1.21	31.25 ± 0.93	24.46 ± 0.76	30.58 ± 1.13	55.71 ± 1.45
PBMC inactive ()	41.50 ± 1.03	14.13 ± 1.51	30.62 ± 0.94	24.11 ± 0.82	31.13 ± 1.11	54.73 ± 1.66
PBMC all patients ()	41.53 ± 0.97	13.96 ± 1.39	30.88 ± 0.97	24.26 ± 0.80	30.90 ± 1.13	55.14 ± 1.62
Neutrophil control ()	42.88 ± 2.19	14.25 ± 3.68	32.39 ± 1.81	24.87 ± 1.40	28.49 ± 1.03	57.26 ± 3.16
Neutrophil active ()	42.89 ± 0.40	15.17 ± 1.58	30.83 ± 2.60	24.60 ± 0.83	29.40 ± 1.64	55.43 ± 3.11
Neutrophil inactive ()	42.43 ± 1.52	14.91 ± 1.88	30.88 ± 0.97	24.15 ± 0.69	30.06 ± 1.49	55.03 ± 1.50
Neutrophil all patients ()	42.62 ± 1.20	15.02 ± 1.73	30.86 ± 1.79	24.34 ± 0.77	29.78 ± 1.56	55.20 ± 2.26

a, for the frequency of the unmethylated allele (CC) in PBMCs in inactive BD patients versus healthy controls.
b, for the frequency of the unmethylated allele (CC) in PBMCs in BD patients versus healthy controls.
c, for the frequency of the unmethylated allele (CC) in neutrophils in inactive BD patients versus healthy controls.
d, for the frequency of the unmethylated allele (CC) in neutrophils in BD patients versus healthy controls.
e, for the frequency of the partially methylated allele (CC + CC) in neutrophils in inactive BD patients versus healthy controls.
f, for the frequency of the partially methylated allele (CC + CC) in neutrophils in BD patients versus healthy control.